APA citiranje

Levi, M. (2020). Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation. Eur J Intern Med.

Citação norma Chicago

Levi, Marcel. "Tocilizumab for Severe COVID-19: A Promising Intervention Affecting Inflammation and Coagulation." Eur J Intern Med 2020.

MLA citiranje

Levi, Marcel. "Tocilizumab for Severe COVID-19: A Promising Intervention Affecting Inflammation and Coagulation." Eur J Intern Med 2020.

Opozorilo: Ti citati niso vedno 100% točni.